Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Poop pills for heart health? new study tests gut bacteria transplant in diabetes patients

NCT ID NCT07421947

First seen Feb 19, 2026 · Last updated Jun 19, 2026 · Updated 18 times

Summary

This pilot study tests whether transferring gut bacteria from a healthy donor (fecal microbiota transplant) can change the gut microbiome of 30 people with type 2 diabetes and stable coronary artery disease. Participants receive the transplant via colonoscopy and are monitored for 6 months to see if their gut bacteria, blood sugar, cholesterol, and inflammation improve. The goal is to gather safety and feasibility data, not to prove a cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University Hospital Zurich

    Zurich, Canton of Zurich, 8091, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

coronary artery disorder Inflammation type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.